Search Results for “vaccination guidelines”

Showing 21-29 of 29

May 31, 2019

FDA: Company voluntarily recalls injectable versions of popular NSAIDs

A pharmaceutical company in the UK is voluntarily recalling 34 lots of veterinary injectable drug products due to sterility concerns, according to the FDA. Norbrook Laboratories in Newry, Northern Ireland, issued the recall May 24, that if the sterility of these drugs has been compromised, using them could introduce infectious agents to the animals.

September 16, 2008

Compounding: Stay afloat in the muddy regulatory waters

Compounding drugs for animal patients is regulated by 50 different state boards of pharmacy and murky federal laws. Although compounded drugs are not approved by the Food and Drug Administration (FDA), they are allowed when approved drugs are not available or suitable for the intended use. Veterinarians should remember a few key things in order to stay safe and on the right side of the law. Potency, safety, efficacy and bioavailability are not guaranteedCompounding from bulk chemicals is in a “regulatory void”Compounds may only be distributed to the patient for which they were prescribedCompounding to make a cheaper version of an approved drug that already exists is illegal Use a PCAB-accredited compounding pharmacy when possible

January 24, 2018

Food stamps for pets?

Low-income Americans are having a hard enough time feeding themselves. Feeding their pets is an even bigger challenge. Some 42 million Americans received benefits from the Supplemental Nutrition Assistance Program (SNAP) last year.

April 29, 2019

FDA: Jurox voluntarily recalls two lots of Alfaxan after reports of adverse side effects, including one death

After receiving adverse reports involving five animals, Australia-based Jurox Animal Health voluntarily recalled two lots of the widely used intravenous injectable anesthetic Alfaxan unpreserved last week, according to the US Food and Drug Administration (FDA). The reason for the recall: The presence of aluminum phosphate precipitate, which, when injected, presents a possible risk of blood vessel inflammation and formation of potentially life-threatening blood clots.

August 27, 2018

No more needles: New research could mean cure for dogs, humans with Type 1 diabetes

Okay, maybe just one needle every three months. But one shot every 90 days sure beats daily insulin injections, if promising new research out of Purdue University bears fruit. Last week, the school released the preliminary findings of a new study: The first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days in test subjects.

January 11, 2019

Study: Rise in veterinary opioid prescriptions could contribute to human opioid epidemic

A new study by researchers at the University of Pennsylvania’s Perelman School of Medicine and the School of Veterinary Medicine reviewed all opioids dispensed at the veterinary school for from January 2007 through December 2017. The findings show that prescriptions rose 41% annually, while the number of patient visits rose only 13%.The researchers found the ratio worrisome.

December 27, 2017

Reporting animal abuse just got easier

“Veterinarians who want to report suspected animal abuse often encounter a bureaucratic runaround,” says Phil Arkow. Arkow hopes that the recent launch of a free online National Directory of Abuse Investigation Agencies will help. Arkow is Coordinator of the National Link Coalition, a multidisciplinary, collaborative initiative formed in 2008 to raise awareness of the connection between animal abuse, child abuse, and domestic violence. It’s based on the idea that violence begets violence, and that when animal cruelty or neglect exists in a home, chances are that children, domestic partners, or elderly family members are being hurt, too.

March 14, 2018

There’s never been a better time for an opioid shortage

The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.

Refine Results


NEWStat

keyboard_arrow_down keyboard_arrow_up